The drugs, which have historically been prescribed to diabetic patients, also help patients lose weight and have grown in popularity among doctors and patients
Key considerations include: Under-dosing risks: Insufficient receptor engagement may yield minimal benefit
Dr Hungerford says we need more long-term, large-scale studies to see how these medications impact people living with eating disordersincluding what happens when they stop using them as weight gain can be triggering for someone experiencing, or at risk of developing, an eating disorder
3 These agents have also been shown to lower levels of circulating proinflammatory cytokines such as TNF- and IL-6, both implicated in HS pathogenesis, as well as C-reactive protein (CRP), a marker of systemic inflammation that correlates with disease severity
In CD4+ T cells, mitochondrial mass was also not altered in ME/CFS (254)